SmartTab™ by Veloce Digital Health to Present Successful Pre-Clinical Animal Studies during the J.P. Morgan 38th Annual Healthcare Conference

January 03 12:48 2020
SmartTab™ by Veloce Digital Health to Present Successful Pre-Clinical Animal Studies during the J.P. Morgan 38th Annual Healthcare Conference
Veloce Digital Health has developed a wireless remote controlled drug delivery system called SmartTab™.
The wireless ingestible capsule has completed Pre-Clinical Animal Studies and will soon enter Human Clinical Trials.

DENVER, CO – Founder & CEO of SmartTab Robert Niichel will present findings at the Startup Health Festival and Digital Medicine & Medtech Showcase 2020 during the J.P. Morgan 38th Annual Healthcare Conference. The events will take place on January 13-16 in San Francisco. This conference brings thousands of investors together to develop innovations in healthcare including pharmaceutical firms, healthcare service providers, nonprofits and medical device companies.

Conference Highlights

  • StartUp Health Festival is a festival that gathers CEOs, investors, world leaders and entrepreneurs focused on solving the world’s biggest health challenges. StartUp Health TV will interview Founder/CEO Robert Niichel at 11:15 PST on Jan. 14. Watch it live on startuphealth.com
  • Digital Medicine & Medtech Showcase is the dedicated home for the digital health and medtech communities during one of the healthcare industry’s biggest weeks. Founder/CEO Robert Niichel will present at 10:45 a.m. PST on Jan. 15. Attend the talk at Parc 55 – A Hilton Hotel, 55 Cyril Magnin Street in the Davidson (Level 4).


Successful Pre-Clinical Animal Studies

With 40-50 percent of all prescription drug consumption not compliant, SmartTab is destined to make a profound impact on healthcare delivery. Prescription pills are often delivered to the wrong site, at the wrong time and without feedback. This process results in wasted medication, ineffective treatments and high toxicity. The remote-controlled SmartTab capsule is poised to change these shortcomings and revolutionize the healthcare industry.

SmartTab achieved a milestone this year. Pre-clinical animal studies of the wireless ingestible capsule were successfully completed. Human Clinical Studies begin in 2020, followed by FDA submission. This is a game changer to improve patient outcomes and help people lead healthier lives.

About SmartTab™ by Veloce Digital Health

Veloce is developing the SmartTab Drug Delivery and Monitoring System, a wirelessly powered and remote controlled ingestible capsule that contains an electronic receiver/monitor, smart polymer actuator, and active ingredients. This precision digital delivery ingestible capsule can be remotely triggered via an external device. It will deliver the active ingredients to highly specific areas in the human body.

The system will interface with custom or current wearable and monitoring technology to interact with Learning Artificial Intelligence (AI) Healthcare Systems. The SmartTab has the capability to interact with the Internet of Medical Things (IoMT), optimize patient outcomes, significantly increase prescription drug adherence, and drastically reduce healthcare costs.

Media Contact
Company Name: SmartTab™ by Veloce Digital Health
Contact Person: Sacha Heppell
Email: Send Email
Phone: 720-220-4152
City: DENVER
State: CO
Country: United States
Website: smarttab.co